Shareholders meeting

July 10, 2026 To, To, Listing Operation Department Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Bandra Kurla Dalal Street, Mumbai-400001 Complex, Bandra (East), Mumbai-400051 (Scrip Code: 544644) (SYMBOL: CORONA) Dear Sir / Madam, Sub.: Declaration of E-voting Results and Scrutinizer Report of the 22nd Annual General Meeting of CORONA Remedies Limited Pursuant to Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the details of the voting results inclusive of the results of remote e-voting and e-voting conducted during the 22nd Annual General Meeting (AGM) of the Company held on Thursday, July 09, 2026, which commenced at 11:00 a.m. and concluded at 12:15 p.m. (including the time allowed for e-voting at the AGM) through Video Conferencing / Other Audio Visual Means. The voting results are enclosed herewith as Annexure – A. The remote e-voting facility remained open from Monday, July 06, 2026 (9:00 A.M. IST) to Wednesday, July 08, 2026 (5:00 P.M. IST). In addition, the Company provided the facility of e-voting during the AGM and for 30 minutes after the conclusion of the AGM to those Members who had not exercised their voting rights through the remote e-voting facility. Further, pursuant to Section 108 of the Companies Act, 2013 read with Rule 20(4)(xii) and Rule 21(2) of the Companies (Management and Administration) Rules, 2014, we are enclosing the Scrutinizer's Report dated July 10, 2026, covering the remote e-voting and e-voting conducted during the AGM. The report has been issued by M/s. Dhara Patel, Company Secretary Firm (ACS No. 29198 / C.P. No. 10979) and is enclosed herewith as Annexure – B. Further, please note that all the resolutions as set out in the Notice dated May 11, 2026 convening the AGM has been passed by the Members of the Company with requisite majority. The voting results along with Scrutinizer's Report are also being uploaded on the Company's website at www.coronaremedies.com and on the website of Central Depository Services (India) Limited at www.evotingindia.com. You are requested to take note of the above. Thanking you. Yours faithfully, For CORONA Remedies Limited Chetna Dharajiya Company Secretary and Compliance Officer Encl.: A/a Details of Voting Results - 22nd Annual General Meeting held on July 09, 2026 Sr. Agenda Type of No. of % of No. of % of No. Resolution Votes in Votes in Votes Votes favour favour Against Against 1 To receive, consider and adopt the Audited Ordinary 59648939 100 2 0 Financial Statements (Standalone and Consolidated) of the Company for the financial year ended March 31, 2026 and the Reports of the Board of Directors and Auditors thereon for the financial year ended March 31, 2026. 2 To declare final dividend of ₹ 10/- each Ordinary 59648953 100 2 0 (Rupees Ten each) (100%) per Equity Share having face value of ₹ 10/- each (Rupees Ten each) for the F.Y. 2025-26. 3 To appoint a Director in place of Mr. Nirav Ordinary 42969641 93.03 3221314 6.97 Mehta (DIN: 01644041), who retires by rotation and being eligible, offers himself for re-appointment. 4 To appoint M/s. Walker Chandiok & Co LLP, Ordinary 56429032 94.6 3219795 5.4 Chartered Accountants, as the Statutory Auditors of the Company and to fix their remuneration. 5 To ratify the remuneration payable to the Ordinary 59648811 100 16 0 Cost Auditors for the F.Y. 2026-27 6 To appoint M/s. Dhara Patel, Company Ordinary 59648854 100 30 0 Secretary Firm as Secretarial Auditors of the Company 7 To approve payment of commission to the Special 56148679 94.13 3500162 5.87 Non Executive Directors of the Company 8 To approve payment of remuneration to Dr. Special 43387058 91.5 4032590 8.5 Kirtikumar Mehta (DIN: 00385658), Non Executive Director and Chairman of the Company for the Financial Year 2026-27 9 Re-appointment of Dr. Kirtikumar Mehta Special 43408354 91.54 4011294 8.46 (DIN: 00385658) as Non Executive Director and Chairman of the Company for a term of 5 (five) years For CORONA Remedies Limited Chetna Dharajiya Company Secretary and Compliance Officer Annexure A ANNEXURE- B